Generics
Upsher-Smith launches Glatiramer Acetate Injection generic
21 August 2026 - Upsher-Smith Laboratories LLC, a US subsidiary of Bora Pharmaceuticals Co Ltd (TW:6472) (OTCQX:BORAY), announced on Thursday the launch of Glatiramer Acetate Injection in 20 mg/mL and...
Annexin Pharmaceuticals receives proposed INN vanexin for ANXV
20 August 2026 - Clinical stage biotechnology company Annexin Pharmaceuticals AB (FN STO:ANNX) said on Thursday that the World Health Organization (WHO) has selected vanexin as the proposed Internatio...
Henlius and Sandoz expand biosimilars collaboration
17 August 2026 - Shanghai-based biopharmaceutical company Shanghai Henlius Biotech, Inc. (HKG: 2696) said on Monday it has agreed a strategic collaboration with generic biosimilars company Sandoz Grou...
Aurisco Pharmaceutical reports successful US FDA inspection
13 August 2026 - Oligonucleotide and peptide (TIDES) manufacturer Aurisco Pharmaceutical Co Ltd (SSE:605116) announced on Wednesday that its site in Yangzhou, China has passed US FDA inspection as the...
Dr. Reddy's launches first-to-market sugammadex injection in the US
4 August 2026 - Indian pharmaceutical company Dr. Reddy's Laboratories Ltd (BSE:500124, NSE:DRREDDY, NYSE:RDY) announced on Tuesday that it has launched Sugammadex Injection 200 mg/2 mL and 500 m...
DifGen Pharmaceuticals' single injection treatment for advanced breast cancer cleared for clinical development
28 July 2026 - Generic pharmaceuticals manufacturer DifGen Pharmaceuticals LLC announced on Monday that the US Food and Drug Administration (FDA) has accepted the company's Investigational New Dr...